A Focus on Ophthalmic Therapies
We are pioneers on a mission to discover, develop, and deliver innovative therapies for ophthalmic disease—maximizing the power of internal expertise and the excellence of strategic partners to help patients in need.
adults around the world are estimated to have dry eye disease
adults in the United States are estimated to suffer from dry eye disease
Dry eye disease affects daily life, including reading and driving at night, and has been associated with depression and migraines. Underlying dry eye disease can limit your ability to tolerate contact lenses and impacts satisfaction in post-op cataract and refractive patients. Despite the high prevalence of dry eye and the burden of the disease, there remains a significant unmet need for effective therapies.
people are estimated to suffer from neurotrophic keratopathy
As NK progresses, epithelial defects and corneal ulcers may develop, causing scarring and astigmatism, which can lead to further loss of vision. Eventually, corneal melting and perforation can result in complete vision loss.